Showing results (431-440 of 493) with videos related to

Sort By:
Pageof 50
International Journal of Cancer|April 11, 2025
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomasTiffanie Chouleur, Christèle Etchegaray, Laura Villain, et al.
Nature Communications|March 10, 2019
Deciphering the complex role of thrombospondin-1 in glioblastoma developmentThomas Daubon, Céline Léon, Kim Clarke, et al.
Blood|July 24, 2012
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myelomaSimona Blotta, Jana Jakubikova, Teresa Calimeri, et al.
Leukemia|March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activityNicola Amodio, Maria Angelica Stamato, Giada Juli, et al.
Cancers|February 6, 2020
The Non-Coding RNA Landscape of Plasma Cell DyscrasiasEugenio Morelli, Annamaria Gullà, Roberta Rocca, et al.
Frontiers in Oncology|March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life SurveyUros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Leukemia|August 19, 2018
miR-22 suppresses DNA ligase III addiction in multiple myelomaDaniele Caracciolo, Maria Teresa Di Martino, Nicola Amodio, et al.
European Journal of Medicinal Chemistry|April 8, 2015
Structure-activity relationship and properties optimization of a series of quinazoline-2,4-diones as inhibitors of the canonical Wnt pathwayArianna Nencini, Carmela Pratelli, Joanna M Quinn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 8, 2017
Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern ItalyRosa Capozzo, Celeste Sassi, Monia B Hammer, et al.
Neurology|June 16, 2026
Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 TumorsFrancesco Bruno, Edoardo Pronello, Luca Bertero, et al.
Pageof 50